search
Back to results

Canadian Varicocelectomy Initiative (CVI): Effects on Male Fertility and Testicular Function of Varicocelectomy (CVI)

Primary Purpose

Male Infertility, Varicoceles

Status
Terminated
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Varicocelectomy
Sponsored by
Mount Sinai Hospital, Canada
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Male Infertility focused on measuring varicocelectomy, male infertility, clinical varicoceles, randomized control trial

Eligibility Criteria

20 Years - 65 Years (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Minimum of one year of infertility
  • Clinically detectable grade 2 or grade 3 varicocele
  • A minimum of 2 abnormal semen analyses (defined as < 20 million sperm/ml, and/or < 30% progressive motility and/or normal sperm morphology < 14% by Kruger Strict Morphology (WHO) within 6 months of entry into the study)
  • Female partner < 38 years of age

Exclusion Criteria:

  • Other medically correctable cause of infertility (e.g., prolactinoma, infection, exposure to marijuana)
  • Severe oligospermia on 2 sperm analyses (defined as < 5 million sperm/ml)
  • Severe asthenospermia on 2 sperm analyses (< 5% progressive motility)
  • Prior varicocele repair
  • Solitary testicle
  • Significant female-factor infertility (tubal factor or anovulation only)
  • Inability or unwillingness to comply with study protocol (including failure to submit 2 post-intervention semen samples)

Sites / Locations

  • Queen Elizabeth II Health Sciences Centre
  • Mount Sinai Hospital
  • McGill University Health Centre; Royal Victoria Hospital
  • McGill University; St. Mary Hospital Centre

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Other

Arm Label

Observation arm

Surgery Arm

Arm Description

Patient will not to undergo any form of Assisted Reproductive Technologies for a period of 6 months

Patients will have varicocelectomy within 1 month of assessment and will not undergo any form of Assisted Reproductive Technologies for a period of 6 months after surgery

Outcomes

Primary Outcome Measures

Pregnancy rates in infertile couples 6 months after surgery or observation alone

Secondary Outcome Measures

Mean improvements in sperm parameters, serum testosterone levels 6 months after surgery or observation alone; complication rate after varicocelectomy; mean time (days) off work after varicocelectomy.

Full Information

First Posted
August 17, 2009
Last Updated
May 24, 2012
Sponsor
Mount Sinai Hospital, Canada
Collaborators
McGill University, Dalhousie University, McMaster University
search

1. Study Identification

Unique Protocol Identification Number
NCT00961558
Brief Title
Canadian Varicocelectomy Initiative (CVI): Effects on Male Fertility and Testicular Function of Varicocelectomy
Acronym
CVI
Official Title
A Prospective, Multi-Centre, Randomized Controlled Study Comparing Varicocelectomy to Observation in Infertile Men With Clinical Varicoceles
Study Type
Interventional

2. Study Status

Record Verification Date
August 2011
Overall Recruitment Status
Terminated
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Mount Sinai Hospital, Canada
Collaborators
McGill University, Dalhousie University, McMaster University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
A varicocele is the presence of dilated testicular veins in the scrotum. Although it is generally agreed that a varicocele is the most common identifiable pathology in infertile men (detected in up to 40% of men in some series of men with infertility), the influence of a varicocele on male fertility potential and role of varicocelectomy in restoring of fertility remain the subject of ongoing controversy. The present controversy on the effect of varicocelectomy on male fertility potential has led many clinicians to dismiss the diagnosis of a varicocele altogether and instead, offer alternative treatments to the couple. Many of these alternative therapies are expensive and risky for the patients and their children. Several recent reviews have critically examined the results of randomized, controlled trials of varicocelectomy on fertility potential. The effect of varicocelectomy on spontaneous pregnancy rates remains controversial. The investigators hypothesize that a varicocelectomy will result in a significant improvement in fertility and testicular function in infertile men with a clinical varicocele.
Detailed Description
INTRODUCTION: A varicocele is the most common detectable factor in infertile men (found in approximately 40% of men with infertility) and varicocelectomy is the most commonly performed surgery to treat male infertility. Despite a large body of literature demonstrating a beneficial effect of varicocele repair on male fertility potential, there is significant controversy about the true effects of varicocelectomy mainly due to the paucity of randomized trials. The present controversy has led many clinicians to dismiss the diagnosis (varicocele) altogether and instead, offer alternative treatments to the couple. These alternative therapies include a variety of unnatural, invasive and costly assisted reproductive techniques such as in vitro fertilization. In-vitro fertilization is in widespread use in the world: in 2002 over 117,000 IVF cycles were performed in the USA with over 1% of newborns in that country being conceived with IVF. One of the major indications for the use of IVF is male factor infertility. The number of infertile couples (in whom the man has a varicocele) presently treated with assisted reproduction is unknown, but is probably at least as high as that undergoing varicocelectomy. Approximately 4500 varicocele repairs are performed in Canada yearly (reference: Canadian Health Institute). The investigators propose a randomized controlled trial on the surgical treatment of clinically detected varicoceles to determine if varicocelectomy results in improved fertility compared to observation alone. This will answer the question about the utility and the role of varicocelectomy in the management of infertile men with a varicocele. RESEARCH QUESTIONS: Primary Question: Among infertile men with clinically detectable varicoceles, does varicocelectomy improve the pregnancy rate over a 6-month period compared to observation alone? Secondary Questions: Among infertile men with clinically detectable varicoceles, does varicocelectomy improve sperm parameters (concentration, motility, DNA integrity) over a 6-month period compared to observation alone? Among infertile men with clinically detectable varicoceles, does varicocelectomy increase serum testosterone levels over a 6-month period compared to observation alone? What is the rate of post-operative complications (recurrence, clinical hydrocele formation and testicular atrophy) after varicocelectomy? What is the average time (days) off work after varicocelectomy? DESIGN ARCHITECTURE: The investigators propose to conduct a multi-centered, randomized controlled trial comparing varicocelectomy to observation alone in infertile men with moderate to large, clinically detectable varicocele. ACCRUAL AND DURATION OF STUDY: To identify a 10% difference in pregnancy rates between the varicocelectomy and control groups we will enroll a total of 300 men (randomized to immediate surgical varicocelectomy or observation alone) and follow these men for 6 months. We anticipate that we will complete recruitment in 3 years. Limiting the study to 6 (rather than 12) months will encourage more couples to participate and is ethically responsible in an era where effective alternative therapies (e.g. IVF) are available. SIGNIFICANCE: The demonstration that varicocelectomy is superior, or not, to observation alone will have a great impact on the treatment of male infertility and on the treatment of the infertile couple as a whole. In addition, the results of this study would have a tremendous financial impact on Canadian Health Care. The results would allow for appropriate use of present treatments and resources for at least 10,000 couples annually in Canada. The results of this study would also impact on the management of infertile couples worldwide.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Male Infertility, Varicoceles
Keywords
varicocelectomy, male infertility, clinical varicoceles, randomized control trial

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
300 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Observation arm
Arm Type
No Intervention
Arm Description
Patient will not to undergo any form of Assisted Reproductive Technologies for a period of 6 months
Arm Title
Surgery Arm
Arm Type
Other
Arm Description
Patients will have varicocelectomy within 1 month of assessment and will not undergo any form of Assisted Reproductive Technologies for a period of 6 months after surgery
Intervention Type
Procedure
Intervention Name(s)
Varicocelectomy
Other Intervention Name(s)
Microsurgical inguinal varicocelectomy, Sub-inguinal varicocelectomy
Intervention Description
Varicocelectomy
Primary Outcome Measure Information:
Title
Pregnancy rates in infertile couples 6 months after surgery or observation alone
Time Frame
7 months after randomization
Secondary Outcome Measure Information:
Title
Mean improvements in sperm parameters, serum testosterone levels 6 months after surgery or observation alone; complication rate after varicocelectomy; mean time (days) off work after varicocelectomy.
Time Frame
7 months after randomization

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Minimum of one year of infertility Clinically detectable grade 2 or grade 3 varicocele A minimum of 2 abnormal semen analyses (defined as < 20 million sperm/ml, and/or < 30% progressive motility and/or normal sperm morphology < 14% by Kruger Strict Morphology (WHO) within 6 months of entry into the study) Female partner < 38 years of age Exclusion Criteria: Other medically correctable cause of infertility (e.g., prolactinoma, infection, exposure to marijuana) Severe oligospermia on 2 sperm analyses (defined as < 5 million sperm/ml) Severe asthenospermia on 2 sperm analyses (< 5% progressive motility) Prior varicocele repair Solitary testicle Significant female-factor infertility (tubal factor or anovulation only) Inability or unwillingness to comply with study protocol (including failure to submit 2 post-intervention semen samples)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Keith A Jarvi, MD
Organizational Affiliation
MOUNT SINAI HOSPITAL
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Armand S Zini, MD
Organizational Affiliation
McGill University
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Kirk C Lo, MD
Organizational Affiliation
MOUNT SINAI HOSPITAL
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ethan D Grober, MD
Organizational Affiliation
MOUNT SINAI HOSPITAL
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Peter T Chan, MD
Organizational Affiliation
McGill University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
John E Grantmyre, MD
Organizational Affiliation
Dalhousie University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Edward G Hughes, MD
Organizational Affiliation
McMaster University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Queen Elizabeth II Health Sciences Centre
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H 2A7
Country
Canada
Facility Name
Mount Sinai Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 1X5
Country
Canada
Facility Name
McGill University Health Centre; Royal Victoria Hospital
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H3A 1A1
Country
Canada
Facility Name
McGill University; St. Mary Hospital Centre
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H3T 1M5
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Canadian Varicocelectomy Initiative (CVI): Effects on Male Fertility and Testicular Function of Varicocelectomy

We'll reach out to this number within 24 hrs